|
2023
|
Invention
|
Combinations of lsd1 inhibitors and menin inhibitors for treating cancer. The instant invention r... |
|
|
Invention
|
Vafidemstat for use in treating autism spectrum disorders.
Provided herein is vafidemstat for us... |
|
|
Invention
|
Methods of treating behavior alterations.
Provided herein are methods for treating behavior alte... |
|
|
Invention
|
Methods of treating malignant peripheral nerve sheath tumor (mpnst) using lsd1 inhibitors. The pr... |
|
|
Invention
|
Methods of treating nf1-mutant tumors using lsd1 inhibitors. The present invention relates to an ... |
|
2022
|
Invention
|
Combinations of lsd1 inhibitors for use in the treatment of solid tumors.
The instant invention ... |
|
|
Invention
|
Combinations of lsd1 inhibitors for treating myeloid cancers.
The instant invention relates to c... |
|
|
Invention
|
Combinations of lsd1 inhibitors for treating myeloid cancers. The instant invention relates to co... |
|
|
Invention
|
1,2,4-oxadiazole derivatives as histone deacetylase 6 inhibitors.
The invention relates to compo... |
|
2021
|
Invention
|
Methods to determine kdm1a target engagement and chemoprobes useful therefor. The invention relat... |
|
|
Invention
|
Combinations of lsd1 inhibitors for the treatment of hematological malignancies.
The instant inv... |
|
2020
|
Invention
|
Vafidemstat for use in treating autism spectrum disorders.
Provided herein are methods for treat... |
|
|
Invention
|
Vafidemstat for use in treating autism spectrum disorders. Provided herein is vafidemstat for use... |
|
|
Invention
|
3-(2-(heteroaryl)-pyridin-4-yl)-5-(trifluoromethyl)-1,2,4-oxadiazole derivatives as hdac6 inhibit... |
|
|
Invention
|
Combinations of iadademstat for cancer therapy.
The present invention relates to combinations, m... |
|
|
Invention
|
Combinations of iadademstat for cancer therapy. The present invention relates to combinations, me... |
|
|
Invention
|
Methods of treating attention deficit hyperactivity disorder using kdm1a inhibitors such as the c... |
|
|
Invention
|
Methods of treating borderline personality disorder. Provided herein are methods for treating bor... |
|
2019
|
Invention
|
Biomarkers and methods for personalized treatment of small cell lung cancer using kdm1a inhibitor... |
|
|
Invention
|
Stable pharmaceutical formulation.
The present invention relates to a pharmaceutical composition... |
|
|
Invention
|
Stable pharmaceutical formulation. The present invention relates to a pharmaceutical composition ... |
|
2018
|
Invention
|
1,2,4-oxadiazole derivatives as histone deacetylase 6 inhibitors. The invention relates to ... |
|
|
Invention
|
1,2,4-oxadiazole derivatives as histone deacetylase 6 inhibitors. The invention relates to compou... |
|
|
Invention
|
Methods of treating behavior alterations. Provided herein are methods for treating behavior alter... |
|
|
Invention
|
Use of a kdm1a inhibitor in the treatment of behavior alterations. Provided herein are meth... |
|
|
Invention
|
(hetero)aryl cyclopropylamine compounds as lsd1 inhibitors. The invention relates to (hetero)aryl... |
|
|
Invention
|
2-(bicyclo-heteroaryl)-isonicotinic derivatives as histone demethylase inhibitors. The invention ... |
|
2017
|
Invention
|
Pharmacodynamic biomarkers for personalized cancer care using epigenetic modifying agents. The in... |
|
|
Invention
|
Biomarkers for determining responsiveness to lsd1 inhibitors. The present invention relates to me... |
|
|
Invention
|
Arylcyclopropylamine based demethylase inhibitors of lsd1 and their medical use. The invention re... |
|
|
Invention
|
Method of treating multiple sclerosis employing a lsd1-inhibitor. Provided herein are methods for... |
|
|
Invention
|
Methods of treating multiple sclerosis. The present disclosure provides a new medicament fo... |
|
|
Invention
|
Heteroaryl-carboxamides as histone demethylase inhibitors. The invention relates to heteroaryl-ca... |
|
|
Invention
|
Combinations of lsd1 inhibitors for the treatment of hematological malignancies. The instant inve... |
|
2016
|
Invention
|
Gene expression biomarkers for personalized cancer care to epigenetic modifying agents.
The pres... |
|
|
Invention
|
Biomarkers associated with lsd1 inhibitors and uses thereof.
The invention relates to biomarkers... |
|
|
Invention
|
Solid forms. The instant invention relates to novel solid forms of the compound of formula (I) or... |
|
2015
|
G/S
|
Research, discovery and development of therapeutic products and diagnostic products and methods i... |
|
|
G/S
|
Pharmaceutical products for human use; diagnostic products
for medical use; all excluding pharma... |
|
2011
|
G/S
|
Diagnostic apparatus for oncological, proliferative, neurodegenerative, inflammatory, metabolic a... |
